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Purpose: We evaluated the incidence of acute kidney injury in a cohort of marathon 
participants. Methods: We conducted a prospective observational study focused on 
evaluating the incidence of kidney damage after a marathon, and its evolution in the first 48 h 
after the marathon in 88 runners who completed the Valencia Marathon. Results: From the 
88 participants, 42 (48.28%) presented with acute kidney injury, mainly grade 1 (95.20%). 
Microscopic haematuria was observed in 29 runners (33%). Levels of interleukin 6, 
leukocytes, and neutrophils were markedly increased at the marathon’s finish line. 
Conclusions: Our results confirmed that there are slight transient changes in glomerular 






Since the study of Behrman [1] in 1941, it is well known that the physical stress of 
marathon running is associated with renal function alterations and urinary abnormalities. In the 
following years, several observational studies evaluated the impact of exhaustive physical 
exercise on the pathophysiology of renal injury and failure [2]. However, most of them assumed 
the classic dogma, which stated that the biochemical alterations observed in runners are the 
consequence of skeletal muscle destruction and dehydration caused by physical stress; the 
possibility of having intrinsic renal damage was ignored. Consequently, any research represents 
a step forward in elucidating the specific cause of pathological urinary changes. 
Since long-distance races have substantially increased in popularity in recent years [3, 
4], a renewed interest in understanding the exercise-related mechanisms altering renal function 
has emerged. Recently, 2 independent studies showed (by measuring novel biomarkers of 
kidney damage) a clear impact of high-intensity exercise on renal function, which seems to be 
independent of both dehydration and skeletal muscle destruction [5, 6]. The results of both 
studies pointed out the key role of systemic inflammation in kidney damage. Systemic 
inflammation has been observed in marathon runners independent of renal function [7–9].
In this study, we evaluated the incidence of acute kidney injury (AKI) after marathon 
running in a cohort of 88 individuals, and the evolution of this alterations 48 h after the 
marathon.
Material and Methods
Sample Subset Selection and Study Design
All participants of the Valencia Marathon 2016 received an invitation by e-mail to 
participate in this study. Two informative seminars were organized to fully explain the study 
design (aims, protocol, hypothesis, etc.) to those individuals who accepted the invitation (n = 
456). A total of 105 recreational marathon runners were selected to participate in this study, 
according to the following inclusion criteria: (1) an age between 30 and 45 years; (2) a body 
mass index (BMI) of between 16 and 24.99; (3) previous marathon experience, having a best-
performance time of between 3 and 4 h for males and between 3:30 and 4:30 h for females; and 
(4) general good health, free from cardiac or renal disease and dyslipidemia. The selected 
participants had trained regularly during the last 6.76 ± 3.19 years and had finished an average 
of 3.24 ± 3 marathons. During their preparation for the Valencia Marathon, they trained an 
average of 4.78 ± 0.89 days a week, covering 62 ± 13.52 km.
On the 22nd of November 2016, a total of 95 individuals started the Valencia Marathon, 
88 of whom (74 males and 14 females) crossed the finish line and were thus included in the 
study.
Prior to starting the study, all subjects performed a cardiopulmonary exercise test on a 
treadmill (pulsar® 3p, h/p/cosmos Sports and Medical GmbH, Nussdorf-Traunstein, Germany) 
until exhaustion. Breath-by-breath gas exchange was measured by the Jaeger MasterScreen® 
CPX gas analyzer to identify the first ventilatory threshold (VT1), the second ventilatory 
threshold (VT2), and the maximal oxygen consumption (O2max) [10–12].
Data Collection
A web-based questionnaire was used to collect demographic and medical information, 
the training plan, and competition history. 
The day before the marathon, anthropometric data (height and body mass) of all 
individuals was evaluated. Height was measured using a SECA 213 portable stadiometer (seca 
GmbH & Co. KG, Hamburg, Germany). Body mass was assessed with light sport clothing and 
barefoot using a SECA 813 (seca GmbH & Co. KG). BMI was then calculated. For the 
estimation of water balance, body mass was also measured both 1 h before the marathon start 
and after crossing the finish line. A medical examination was carried out by a nephrology 
specialist to assess dehydration data (skin and mucous dryness and skin-fold thickness). 
Hydration during the marathon was recorded in a personal interview of subjects.
Collection points of blood and urine samples as well as the biochemical markers 
analyzed in these samples are summarized in Table 1. Blood samples were taken from runners’ 
antecubital veins by venipuncture using BD Vacutainer PST II tubes, centrifuged at 3,500 rpm 
for 10 min, and transported to a hospital in Valencia at 4°C for biochemical analysis. The impact 
of modifications in plasma volume due to dehydration was taken into account according to the 
recommendations of Kargotich et al. [13]. To this end, the biochemical results collected at the 
post-marathon time points were adjusted with the method of Dill and Costill [14], using 
haematocrit and haemoglobin to determine the magnitude of plasma volume changes after the 
race in each participant [14, 15]. The Chronic Kidney Disease Epidemiology Collaboration 
(CKD-EPI) equation was used to calculate the glomerular filtration rate (GFR) [16].
Definition of AKI
Acute Kidney Injury Network (AKIN) international criteria were applied. Grade 1 AKIN is 
defined as a sudden reduction of renal function determined by an absolute increase in serum 
creatinine of at least 0.3 mg/dL within 48 h (≥26.4 μmol/L), or at least 50% (1.5-fold) from 
baseline [17]. Grade 2 AKIN is considered when serum creatinine levels increase >200–300% 
from baseline [17]. Grade 3 AKIN represents an increase in serum creatinine >300% from 
baseline, or a level of ≥4 mg/dL with an acute increase of at least 0.5 mg/dL. As it was not 
possible to collect the urine output, this was not taken into account. Haematuria is distinguished 
by the abnormal presence of red blood cells (≥5 red blood cells per high-power field) in the urine 
[18].
Statistical Analysis
The Kolmogorov-Smirnov test was used to test for the normality of data distribution. 
Mean and standard deviation [SD] for normally distributed continuous variables, median and 
interquartile range [IQR] for non-normally distributed continuous variables, and n (%) for 
categorical variables were used to report study data.
For categorical variables, McNemar’s test was applied to compare data from different 
collection points within the same individual or group, while the χ2 test was used to evaluate 
differences between recovery groups.
For normally distributed continuous variables, repeated-measures ANOVA was used to 
compare data from different collection points within the same individual or group. Bonferroni’s 
post hoc test was used for pairwise comparisons. For non-normally distributed continuous 
variables, Friedman’s test was applied to compare data from different collection points within the 
same individual.
Statistical analysis was done using SPSS software v23, and two-sided p values <0.05 
were considered statistically significant.
Results
The information collected from the 88 individuals included in this clinical trial is 
summarized in Table 1.
Forty-two of 88 participants (48.28%) presented with AKI after the marathon (Table 2). 
Nobody exhibited grade 3 AKI. We note that, in this case, statistical analyses were done using 
data obtained from 87 participants, since the blood sample of 1 participant at the finish line 
collection point was not available. We did not find any clinical (BMI, hydration status, weight 
loss, age, and sex) or analytical (CRP, Il-6, GFR, etc.) statistically significant differences 
between AKI and non-AKI participants. 
Remarkably, haemoglobin was the only marker whose mean values before the marathon 
and at the finish line were not significantly different (p > 0.05) (Table 3). Sodium levels in the 
urine were considerably decreased at the finish line collection point. Indeed, we observed 
alterations related to transient changes in glomerular filtration, such as the increase of the 
albumin/creatinine ratio in the urine and the percentage of runners with haematuria.
The blood analyses also showed a notable reduction of the GFR after crossing the finish 
line. After 24 h, these GFR values returned to normal (Fig. 1). However, a slight, but significant, 
decrease in GFR was also observed at the 48-h post-marathon collection point. Although 
changes in GFR levels were not clinically significant (i.e., they were within the normal range) at 
48 h, this reduction suggests the importance of maintaining intensive oral hydration, not only 
during the first 24 h post-marathon when the protective mechanism of thirst is more intense, but 
also until at least 48 h after racing with vigorous physical effort. 
We followed up all participants until 144 h. At this time point, all of them had recovered 
their basal GFR, with no differences between those in whom it had decreased and those in 
whom it had not. 
Discussion
The popularity of studying mechanisms altering renal function after high-intensity 
exercise has risen considerably over the last few years [19, 20]. This prospective cohort study 
recruited a considerable number of volunteer marathon runners compared to previously 
published studies [6, 21]. 
High-intensity exercise was confirmed to impact on renal function, since approximately 
half of the runners (48.28%) presented with AKI after the marathon, and microscopic 
haematuria was observed in one-third (33.00%). Indeed, the level of microalbuminuria reached 
was considerably high compared to normal conditions (59.78 ± 89.50 vs. <10 mg/dL).
Our results were consistent with the observations by McCullough et al. [5] which revealed 
that 40% of 25 subjects presented with acute renal failure after running a marathon. However, 
this percentage was considerably higher in a very recently published study (82% of 22 runners 
showed renal failure) [6]. The slight difference between McCullough et al. [5] and our study may 
be due to differences in the average completion time of the runners (256.2 ± 43.5 vs. 214 ± 20.8 
min), assuming that a faster marathon time may be associated with a higher physical effort, 
and, therefore, with a greater impact on runners’ health status. Nevertheless, this hypothesis is 
utterly incongruous with the results of the study by Mansour et al. [6], which found that most 
runners presented with AKI despite having a slower marathon time of 240.12 ± 38.4 min. Note 
that none of the previous studies adjusted the biomarker levels collected at the finish line based 
on blood volume loss as should be done [22]. Our non-adjusted results were practically identical 
with those previously published (data not shown). Altogether, our observations may mainly differ 
from previous published because of the sample size. Having a larger sample size produces 
results that are more representative. Therefore, the incidence of renal alterations after marathon 
running could be more accurately studied in this study.
Like in McCullough et al. [5] and Mansour et al. [6], most of the renal alterations were 
grade 1. Renal alterations were confirmed to be completely recovered in a short period of time 
[5, 6, 23]. In contrast to previous classical studies [24–26], none of the runners displayed severe 
renal failure, severe rhabdomyolysis, or multiorgan failure, and there were no deaths after the 
marathon. We speculate that, nowadays, runners are better physically prepared and informed 
about the risks of dehydration. 
Unlike serum creatinine (the level of which may be modified by the breakdown of 
muscular fibres), serum creatine kinase (CK) did not reach its maximum level at the finish line 
but rather at the 24-h post-marathon collection point, when the creatinine level had returned to 
normal. This observation, also shown in a cohort study of 34 marathoners [27], confirmed that 
renal alterations are not a mere “biochemical illusion” subsequent to the release of muscular 
intracellular components as a result of the breakdown of muscle fibres. This is also supported 
by McCullough et al. [5] and Mansour et al. [6], who revealed an increased level of tubular 
kidney damage-specific biomarkers that appears to be independent of muscle mass and 
dehydration status, such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury 
molecule-1 (KIM-1), and cystatin C.
Even so, reaching the maximum CK level 24 h after the marathon, together with the fact 
that both uric acid and lactate dehydrogenase remained high with respect to baseline levels 48 
h post-marathon, suggests that the reduction of GFR observed at the 48-h collection point may 
have been due to the late arrival of intracellular toxic waste to the kidney.
Additionally, as previously shown [5, 6], urinary sodium is reduced after running a 
marathon because, in response to the body fluid loss, a healthy kidney retains sodium and 
therefore water. As result, a small volume of more concentrated urine is excreted (the sodium is 
less diluted) [28]. Urine sodium levels were not associated either with the development of acute 
renal failure, or with the second GFR reduction observed during the post-marathon follow-up 
period.
Taking everything into account, neurohormonal mechanisms derived from inflammatory 
activity and/or oxidative stress may be involved in renal failure, since it appears that tubular 
injury is not the only cause of renal alterations observed in runners after a marathon. Indeed, we 
also found urinary alterations, such as microalbuminuria and microhaematuria, which are 
derived from alterations in glomerular permeability. The fact that alterations in glomerular 
permeability underlie most chronic kidney disorders, due to the accumulation of cardiovascular 
risk factors [29], highlights the importance of this assumption which should be confirmed by 
further specifically designed studies. The transient renal alterations found in marathoners 
(healthy individuals who did not present with cardiovascular risk factors or chronic renal 
disorders) may represent an excellent model (free of confounding variables) to study the role of 
inflammation and oxidative stress in renal autoregulatory mechanisms. 
On the one hand, a fluid sequestration within the muscles and an imbalance between 
vasodilation and vasoconstrictor agents because of the endothelial dysfunction development 
derived from the release of myoglobin into the circulation have been shown during strenuous 
physical exercise [30]. Both conditions lead to the activation of the renin-angiotensin-
aldosterone system (RAAS), and therefore to intrarenal vasoconstriction [30].
On the other hand, alterations in microvascular blood flow and leukocyte recruitment are 
clearly correlated through the ischemia/reperfusion phenomenon [31]. Under these 
circumstances, as confirmed by our results, reactive oxygen species (ROS) and inflammatory 
mediators increase leukocyte activation and recruitment. This, in turn, intensifies inflammation, 
endothelial activation, and vascular tone. Indeed, as shown in our marathon runners, the renal 
epithelium also generates interleukin 6 (IL-6), a cytokine that triggers the inflammatory cascade 
[32]. IL-6 is shown to aggravate kidney damage in rats [33, 34], and also in humans with 
ischaemic renal damage who are undergoing cardiac surgery [35].
Further studies are needed to deeply understand these inflammatory mechanisms as 
well as delineate the molecules that block the inflammatory cascade and oxidative stress. 
These chemicals may present a great therapeutic and preventive utility when the renal 
vasculature is compromised by the endothelial dysfunction that they cause. Some of them, such 
as N-acetylcysteine [36], vitamin C [37], and acetaminophen [38], are already being used for the 
treatment of other indications, and they have a high safety profile. Indeed, they have been 
positively tested in animal models that reproduce the type of AKI observed in our subjects after 
marathon running. Future clinical studies in human models (i.e., healthy marathoners) that 
focuses on testing the effect of anti-inflammatory and anti-oxidative chemicals in renal failure 
prevention should be considered.
Practical Applications and Conclusions
In conclusion, we observed slight transient changes in GFR after marathon running as 
well as data that indicated glomerular structural damage (microalbuminuria and haematuria). 
However, our data suggests that the long-term repercussions of these in renal function are not 
foreseeable since such alterations were immediately normalized (all data returned to normal 
values at 24–48 h after the marathon). This is important information for coaches and runners. 
According to our data, mechanisms of inflammatory origin involved in endothelial 
dysfunction could trigger the renal alterations observed after marathon running. These results 
can encourage researchers to develop clinical studies focused on testing the effect of anti-
inflammatory and anti-oxidative chemicals for the prevention of AKI. A large-scale, prospective 
study evaluating biomarkers related to renal failure in athletes, such as NGAL and KIM-1, before 
(in the preparation phase) and after (in the recovery phase) competing is necessary to confirm 
our findings.
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Legend(s)
Fig. 1. Evolution of glomerular filtration rate alterations after running a marathon. A comparison 
of data from 4 collection points was performed. Data collected from the start line to 48 h 
post-marathon running was used. FL, finish line; SL, start line. Asterisks denote ■■■.
Table(s)
Footnote(s)





Type 1 diabetes 00.001 (1.14)
Smoking 00.005 (5.70)
Use of non-steroidal anti-inflammatory 
drugs 000.14 (15.90)
Number of days resting after marathon 
running 0006.5 (3–7)
Use of isotonic drinks during marathon 
running 000.66 (79.51)
Fluid intake during marathon running, L 001.50 (1.00–
2.00)
Body mass loss after marathon running, 
kg
002.12±0.87
Skin and mucous dryness 000.50 (63.30)
Skin-fold thickness 000.15 (18.75)
Number of cramps during the marathon 00.020 (23.81)
Average marathon time, min 214.79±20.83
Data is presented as mean ± SD for normally distributed 
continuous variables, median (interquartile range) for non-
normally distributed continuous variables, and n (%) for 
categorical variables.
Table 2. Incidence of acute renal failure after running the marathon
Absence of AKI 45 (51.72)
Presence of AKI 42 (48.28)
Grade 1 40 (95.24)
Grade 2 02 (4.76)
Presence of haematuria 29 (33.00)
Data is presented as n (%). AKI, acute kidney injury.
Table 3. Data of subjects at the 4 collection time points





82 Haemoglobin, g/dL 014.69±0.95 014.82±1.02 13.70±0.92b 13.88±0.84b <0.00
1
82 Leukocytes, 106/μL 007.14±1.75 017.39±3.94b 7.61±1.50 7.27±1.30 <0.00
1
82 Neutrophils, 106/μL 004.11±1.32 014.50±3.67b 4.22±1.20 3.879±0.86 <0.00
1
84 CPR, mg/dL 000.04 (0.02–0.05)b 004.85 (4.68–5.01)b 1.22 (0.90–1.60)b 0.67 (0.47–0.82)b <0.00
1
85 IL-6, pg/mL 003.10 (2.18–5.60) 083.75 (64.72–130.14) n.a. n.a. <0.00
1
81 Creatinine, mg/dL 000.96 (0.80–1.10) 001.31 (1.17–1.47)b 0.94 (0.80–1.00) 1.01 (0.90–1.10)b <0.00
1
81 GFR, mL/min/1.73 m2 081.92 (66.13–98.75) 053.65 (45.12–60.53)b 84.92 (68.93–102.28) 75.98 (63.62–94.58)b <0.00
1
82 Urea, mg/dL 034.00 (29.00–40.00)b 042.32 (37.60–46.66)b 38.00 (33.00–45.00)b 35.00 (30.75–41.25)b <0.00
1
82 CK, UI/L 136.00 (106.00–183.00)b 340.27 (268.01–
432.44)b




81 LDH, UI/L 175.00 (160.00–197.00)b 306.18 (274.54–
362.06)b










81 Microalbuminuria, mg/dL 002.25 (1.50–5.23)c 032.35 (13.88–58.33)c n.a. 1.60 (0.70–2.90)c <0.00
1
88 Urinary sodium, mEq/L 089.50 (60.25–114.75) 039.50 (21.00–62.25)c n.a. 86.00 (58.25–134.75) <0.00
1
81 ACR, mg/g 001.95 (1.20–2.88)c 017.80 (11.00–28.88)c n.a. 1.50 (1.00–2.40)c <0.00
1
88 Microhaematuria 0000.6 (6.80%) 000.29 (33.00%)c n.a. 3 (3.40%) <0.00
1
Data is presented as mean ± SD for normally distributed continuous variables, median (interquartile range) for non-normally distributed continuous variables, 
and n (%) for categorical variables. Data from blood samples was adjusted following Dill and Costill’s method [14]. N, number of runners; CK, creatine kinase; IL, 
interleukin; LDH, lactate dehydrogenase; CPR, C-reactive protein; GFR, glomerular filtration rate (calculated by the CKD-EPI equation [16]); ACR, albumin/
creatinine ratio; n.a., not available. Conversion factors for units: serum creatinine in mg/dL to μmol/L, × 88.4; urea nitrogen in mg/dL to mmol/L, × 0.357; uric acid in 
mg/dL to μmol/L, × 59.48.
a p values were calculated with McNemar’s test, repeated-measures ANOVA, and Friedman’s test for categorical variables, normally, and non-normally 
distributed continuous variables, respectively. Pairwise comparisons were done by applying the Bonferroni and Wilcoxon-Mann-Whitney post hoc tests for normally 
and non-normally distributed continuous variables, respectively.
b Statistically significantly different from the other 3 collection points.
c Statistically significantly different at 2 collection points. 
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